Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)

SHE:002412 Revenue

Hunan Hansen Pharmaceutical had revenue of 212.94M CNY in the quarter ending June 30, 2026, a decrease of -11.11%. This brings the company's total for the last twelve months to 1.01B, down -2.59% year-over-year. In the year 2025, Hunan Hansen Pharmaceutical had annual revenue of 1.04B with 3.41% growth. That makes Hunan Hansen Pharmaceutical the 19,586th largest company in the world by revenue and 3,576th in China.

• Revenue (ttm): 1.01B
• Revenue Growth: -2.59%
• P/S Ratio: 3.79
• Revenue / Employee: 477.27K
• Employees: 2,108
• Market Cap: 3.81B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical Industry 1.04B 99.9%
• Unallocated Others 976.86K 0.1%

Fiscal year ended Dec 31, 2025 See the full SHE:002412 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.04B	34.29M	3.41%
Dec 31, 2024	1.00B	48.94M	5.12%
Dec 31, 2023	955.53M	39.47M	4.31%
Jan 1, 2023	916.06M	24.23M	2.72%
Jan 1, 2022	891.84M	150.60M	20.32%

Data Source: S&P Global Market Intelligence Last updated: Aug 24, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error